News
Recent news about Panacea Venture and select portfolio companies
April 19, 2024
Immunogenicity of Innovative and Biosimilar Monoclonal Antibodies
April 19, 2024
Immunogenicity of Innovative and Biosimilar Monoclonal Antibodies
April 9, 2024
Mr. Huang Guo, Deputy Commissioner of China NMPA Visits Chime Biologics Wuhan Headquarter
April 9, 2024
Mr. Huang Guo, Deputy Commissioner of China NMPA Visits Chime Biologics Wuhan Headquarter
April 8, 2024
Poster: AACR (American Association for Cancer Research), April 5-10, 2024, San Diego CA
A systemically delivered, clinically-ready, attenuated Salmonella Typhimurium strain ACTM-838 alters the tumor microenvironment and provides durable anti-tumor activity in vivo VIEW POSTER PDF
April 8, 2024
Poster: AACR (American Association for Cancer Research), April 5-10, 2024, San Diego CA
A systemically delivered, clinically-ready, attenuated Salmonella Typhimurium strain ACTM-838 alters the tumor microenvironment and provides durable anti-tumor activity in vivo VIEW POSTER PDF